https://ir.newamsterdampharma.com/ 2024-11-08T15:50:34-05:00 daily 1.0 https://ir.newamsterdampharma.com/committee-details/audit-committee 2026-04-22T09:42:55-04:00 0.5 https://ir.newamsterdampharma.com/committee-details/compensation-committee 2026-04-22T09:43:26-04:00 0.5 https://ir.newamsterdampharma.com/committee-details/nominating-and-corporate-governance-committee 2024-07-19T16:38:30-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/svb-global-biopharma-conference 2023-02-09T08:01:11-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/cowen-43rd-annual-health-care-conference 2023-03-01T08:02:34-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/newamsterdam-pharma-conference-call 2023-06-15T16:30:26-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/jefferies-healthcare-conference 2023-05-31T08:01:55-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/2023-cantor-fitzgerald-global-healthcare-conference 2023-09-20T08:01:01-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/piper-sandler-35th-annual-healthcare-conference 2023-11-13T08:05:18-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/jefferies-london-healthcare-conference-2023 2023-11-13T08:04:55-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/guggenheim-healthcare-talks-6th-annual-biotechnology-conference 2024-02-01T16:02:53-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/td-cowen-44th-annual-health-care-conference 2024-02-26T08:01:50-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/leerink-global-biopharma-conference 2024-02-26T08:01:42-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/newamsterdam-pharma-rd-day 2024-05-16T12:13:55-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/2024-rbc-capital-markets-global-healthcare-conference 2024-05-09T09:18:55-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/jefferies-global-healthcare-conference 2024-05-29T08:05:03-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/goldman-sachs-45th-annual-global-healthcare-conference 2024-06-10T13:35:19-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/newamsterdam-pharma-conference-call-0 2024-07-26T18:57:13-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/morgan-stanley-22nd-annual-global-healthcare-conference 2024-09-04T15:26:42-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/cantor-global-healthcare-conference 2024-09-04T15:26:45-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/jefferies-london-healthcare-conference 2024-10-31T14:50:48-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/2024-american-heart-association-aha-scientific-sessions 2024-11-18T10:40:34-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/tandem-conference-call 2024-11-20T07:00:49-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/newamsterdam-conference-call 2024-12-10T08:26:58-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/guggenheims-smid-cap-biotech-conference 2025-01-29T09:40:27-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/td-cowen-45th-annual-healthcare-conference 2025-02-25T08:04:36-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/leerink-partners-global-healthcare-conference-2025 2025-02-25T08:04:39-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/24th-needham-virtual-healthcare-conference 2025-03-31T08:01:59-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/2025-rbccm-global-healthcare-conference 2025-05-21T21:02:30-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/william-blair-45th-annual-growth-stock-conference 2025-05-27T08:04:07-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/jefferies-global-healthcare-conference-2025 2025-05-27T08:04:27-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/goldman-sachs-46th-annual-healthcare-conference 2025-05-27T16:10:54-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/newamsterdam-pharma-rd-day-2025 2025-06-10T21:54:37-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/newamsterdam-conference-call-aaic-2025 2025-07-29T17:11:00-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/citis-2025-biopharma-back-school-conference 2025-08-25T08:00:00-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/cantor-global-healthcare-conference-2025 2025-08-27T11:32:49-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/2025-wells-fargo-healthcare-conference 2025-08-25T08:00:00-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/european-society-cardiology-congress-esc-2025 2025-08-25T08:31:01-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/stifel-2025-virtual-cardiometabolic-forum 2025-09-30T10:53:33-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/guggenheim-2nd-annual-healthcare-innovation-conference 2025-10-30T08:29:42-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/stifel-healthcare-conference 2025-10-30T08:29:38-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/jefferies-london-healthcare-conference-0 2025-10-30T10:19:19-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/citi-global-healthcare-conference 2025-11-25T08:03:42-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/piper-sandler-37th-annual-healthcare-conference 2025-11-25T08:00:00-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/8th-annual-evercore-healthcare-conference 2025-11-25T08:00:00-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/guggenheim-emerging-outlook-biotech-summit-2026 2026-02-04T08:03:01-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/td-cowen-46th-annual-health-care-conference 2026-02-25T08:01:47-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/leerink-partners-global-healthcare-conference-2026 2026-02-25T08:02:10-05:00 0.5 https://ir.newamsterdampharma.com/events/event-details/25th-annual-needham-virtual-healthcare-conference 2026-04-08T08:01:21-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/prevail-update-call 2026-05-07T07:11:57-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/bofa-securities-2026-global-healthcare-conference 2026-05-11T08:52:12-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/2026-rbccm-global-healthcare-conference 2026-05-11T08:55:16-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/jefferies-global-healthcare-conference-2026 2026-05-28T08:01:29-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/goldman-sachs-47th-annual-global-healthcare-conference 2026-05-28T08:01:41-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/newamsterdam-pharma-investor-day-2026 2026-08-05T08:29:03-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/wells-fargo-21st-annual-healthcare-conference 2026-09-02T08:02:03-04:00 0.5 https://ir.newamsterdampharma.com/events/event-details/2026-cantor-global-healthcare-conference 2026-09-02T08:01:39-04:00 0.5 https://ir.newamsterdampharma.com/investor-relations 2024-11-08T15:50:34-05:00 0.8 https://ir.newamsterdampharma.com/news-events/press-releases 2022-09-07T15:29:12-04:00 0.8 https://ir.newamsterdampharma.com/news-events/events-and-presentations 2026-03-02T09:08:00-05:00 0.8 https://ir.newamsterdampharma.com/corporate-governance/governance-overview 2023-05-26T18:08:09-04:00 0.8 https://ir.newamsterdampharma.com/corporate-governance/committee-composition 2022-08-16T11:41:48-04:00 0.8 https://ir.newamsterdampharma.com/financial-information/annual-reports 2025-05-12T14:00:16-04:00 0.8 https://ir.newamsterdampharma.com/stock-information/analyst-coverage 2022-09-07T14:56:44-04:00 0.8 https://ir.newamsterdampharma.com/stock-information/stock-quote-chart 2022-11-22T12:08:24-05:00 0.8 https://ir.newamsterdampharma.com/stock-information/historic-price-lookup 2021-07-21T12:35:35-04:00 0.8 https://ir.newamsterdampharma.com/stock-information/investment-calculator 2021-07-21T12:35:43-04:00 0.8 https://ir.newamsterdampharma.com/shareholder-services/investor-faqs 2022-07-26T12:02:58-04:00 0.8 https://ir.newamsterdampharma.com/shareholder-services/email-alerts 2022-07-26T12:01:37-04:00 0.8 https://ir.newamsterdampharma.com/rss 2023-03-08T11:31:42-05:00 0.8 https://ir.newamsterdampharma.com/ir-resources/annual-meeting-2024 2025-05-12T14:01:26-04:00 0.8 https://ir.newamsterdampharma.com/shareholder-services/contact-ir 2022-07-26T12:00:39-04:00 0.8 https://ir.newamsterdampharma.com/financial-information/quarterly-results 2022-04-04T12:26:01-04:00 0.8 https://ir.newamsterdampharma.com/financial-information/sec-filings 2021-10-20T00:39:34-04:00 0.8 https://ir.newamsterdampharma.com/investor-day 2022-08-16T12:55:46-04:00 0.8 https://ir.newamsterdampharma.com/dutch-statutory-annual-report-2023-0 2025-05-08T16:51:40-04:00 0.8 https://ir.newamsterdampharma.com/dutch-statutory-annual-report-2024-0 2025-05-08T16:50:27-04:00 0.8 https://ir.newamsterdampharma.com/ir-resources/annual-meeting-2025 2026-05-08T10:21:55-04:00 0.8 https://ir.newamsterdampharma.com/financial-information/annual-meeting 2026-05-08T11:43:13-04:00 0.8 https://ir.newamsterdampharma.com/ir-resources/annual-meeting-2023 2025-06-11T15:03:26-04:00 0.8 https://ir.newamsterdampharma.com/ir-resources/annual-meeting-2026 2026-05-08T11:40:07-04:00 0.8 https://ir.newamsterdampharma.com/dutch-statutory-annual-report-2025-0 2026-05-27T14:12:59-04:00 0.8 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-doses-first-patient-phase-3-brooklyn 2022-08-01T12:05:28-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-holding-bv-and-frazier-lifesciences 2022-08-01T12:06:50-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-and-menarini-group-sign-licensing-deal 2022-08-01T12:07:51-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-shares-new-data-phase-2b-rose-study-showing 2022-08-01T12:09:30-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-upcoming-medical-conferences-new 2022-08-01T12:10:09-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/new-meta-analysis-european-heart-journals-cardiovascular 2022-08-01T12:10:46-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-doses-first-patient-phase-2-trial 2022-08-01T12:11:18-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-doses-first-patient-prevail-cardiovascular 2022-08-01T12:12:00-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/new-review-article-escs-cardiovascular-research-examines 2022-08-01T12:12:41-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-doses-first-patient-phase-3-broadway-trial 2022-08-01T12:13:21-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-presents-full-results-phase-2-rose-study 2022-08-01T12:14:04-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-rose-phase-2-trial-results 2022-08-01T12:14:44-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-positive-results-phase-2-study-oral 2022-08-01T12:15:15-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-completes-196m-eu160m-series-funding 2022-08-01T12:15:49-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-publication-nature-medicine 2022-11-21T11:41:33-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-showcases-leadership-cardiometabolic-disease 2022-11-21T11:42:35-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-initiation-phase-2-dose-finding 2022-11-21T11:43:11-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-debuts-publicly-traded-company-focused 2022-11-23T08:00:47-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-announces-appointment-david-topper-chief-financial 2022-12-19T16:01:16-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-announces-positive-results-rose2-phase-2-trial 2023-01-17T08:01:47-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-appoints-john-w-smither-its-board-directors 2023-02-06T08:00:35-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-svb-securities-global-biopharma 2023-02-09T08:00:40-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-cowen-43rd-annual-health-care 2023-03-01T08:01:49-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-full-year-2022-financial-results-and 2023-04-02T21:20:59-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-appoints-janneke-van-der-kamp-its-board 2023-04-03T08:01:01-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-completes-enrollment-pivotal-phase-3 2023-04-24T08:01:12-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-first 2023-05-08T08:00:42-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-present-full-data-rose2-nla-scientific-sessions 2023-05-23T08:00:28-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-jefferies-healthcare-conference 2023-05-31T08:01:19-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-presents-full-data-phase-2-rose2-trial 2023-06-03T12:15:16-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-positive-topline-results-phase-2b 2023-06-05T07:01:05-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-commencement-secondary-offering 2023-06-06T16:01:53-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-pricing-upsized-secondary-offering 2023-06-06T23:26:33-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-closing-upsized-secondary-offering 2023-06-09T16:02:21-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-completes-enrollment-pivotal-phase-3-0 2023-07-25T16:01:34-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-second 2023-08-07T07:15:16-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-appointment-william-bj-jones 2023-08-14T16:01:35-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-2023-cantor-fitzgerald-global 2023-09-20T08:00:32-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-initial-data-phase-2a-clinical 2023-09-21T07:00:40-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-appointment-ian-somaiya-chief 2023-10-23T08:00:30-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-third 2023-11-13T08:01:07-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-2024-strategic-priorities 2024-01-04T08:01:05-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-appoints-william-h-lewis-jd-mba-chair-its 2024-01-08T08:01:29-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-guggenheim-healthcare-talks-6th 2024-02-01T16:02:02-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-commencement-public-offering 2024-02-13T16:01:30-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-pricing-1753-million-public 2024-02-13T22:40:31-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences 2024-02-26T08:00:52-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-full-year-2023-financial-results-and 2024-02-28T08:00:25-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-doses-first-patient-phase-3-tandem-clinical 2024-03-12T08:00:32-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-new-analysis-phase-2-rose2-trial 2024-03-25T08:00:44-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-appointment-juliette-audet-chief 2024-04-01T08:00:20-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-enrolls-over-9000-patients-pivotal-phase-3 2024-04-09T10:29:07-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-host-rd-day-key-opinion-leaders-may-16-2024 2024-05-02T08:01:06-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq 2024-05-03T16:01:32-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-0 2024-05-09T08:01:01-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-new-clinical-and-preclinical-data 2024-05-21T08:01:01-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-0 2024-05-29T08:01:02-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-0 2024-06-07T16:01:19-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-issuance-composition-matter-patent 2024-06-11T08:00:36-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-1 2024-07-03T16:01:55-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-completes-enrollment-pivotal-phase-3-tandem 2024-07-08T08:00:24-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-appointments-mark-c-mckenna-and 2024-07-18T08:00:36-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announce-topline-data-pivotal-phase-3 2024-07-26T16:01:53-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-positive-topline-data-pivotal 2024-07-29T08:01:02-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-2 2024-08-02T16:01:49-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-1 2024-08-07T08:00:29-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-1 2024-08-30T08:00:31-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-3 2024-09-06T16:32:46-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-4 2024-10-04T16:30:41-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-medical-and-investor 2024-10-28T16:30:53-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-5 2024-11-01T17:27:26-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-2 2024-11-06T08:01:45-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-presents-additional-data-pivotal-phase-3 2024-11-18T15:20:12-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-positive-topline-data-pivotal-0 2024-11-20T07:00:38-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-6 2024-12-06T16:01:36-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-positive-topline-data-pivotal-1 2024-12-10T07:00:41-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-commencement-300-million-public 2024-12-10T16:35:34-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-pricing-upsized-4165-million 2024-12-11T21:37:57-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-closing-upsized-4790-million 2024-12-13T17:16:55-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-7 2025-01-09T15:39:41-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-highlights-2024-achievements-and-outlines 2025-01-10T08:01:09-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-guggenheims-smid-cap-biotech 2025-01-29T08:00:19-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-8 2025-02-07T16:01:42-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-2 2025-02-25T08:00:36-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-full-year-2024-financial-results-and 2025-02-26T08:00:52-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-24th-annual-needham-virtual 2025-03-31T08:00:42-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-9 2025-04-04T16:01:13-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-appoints-adele-gulfo-its-board-directors 2025-04-17T16:01:07-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-new-clinical-and-preclinical-data-0 2025-04-30T10:24:33-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-10 2025-05-02T16:01:15-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-late-breaking-data-broadway-and 2025-05-07T07:15:44-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-3 2025-05-08T08:00:52-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-2025-rbccm-global-healthcare 2025-05-14T08:00:46-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-3 2025-05-27T08:00:15-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-host-rd-day-june-11-2025 2025-06-05T08:00:47-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-positive-topline-alzheimers 2025-06-09T07:00:34-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-alzheimers-biomarker-data-broadway 2025-07-22T08:01:17-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-presents-positive-data-broadway-trial 2025-07-30T08:25:49-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-4 2025-08-06T07:00:37-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-announces-acceptance-marketing-authorization 2025-08-22T09:05:50-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-medical-meeting-and 2025-08-25T08:00:42-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-stifel-2025-virtual-cardiometabolic 2025-09-24T08:00:59-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-medical-meeting-and-0 2025-10-30T10:18:02-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-5 2025-11-05T08:00:56-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-11 2025-11-07T16:01:40-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-4 2025-11-25T08:00:44-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-12 2025-12-05T16:01:08-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-13 2026-01-05T16:01:10-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-highlights-2025-achievements-and-outlines 2026-01-09T08:00:45-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-guggenheim-emerging-outlook-biotech 2026-02-04T08:00:37-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-14 2026-02-06T16:01:32-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-full-year-2025-financial-results-and 2026-02-18T07:01:10-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-5 2026-02-25T08:00:21-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-15 2026-03-06T16:01:30-05:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-three-presentations-2026-american 2026-03-23T08:00:54-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-16 2026-04-02T17:44:24-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-present-25th-annual-needham-virtual 2026-04-08T08:00:36-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-17 2026-05-01T16:57:41-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-6 2026-05-07T07:01:07-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-6 2026-05-11T08:41:33-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-7 2026-05-28T08:00:30-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-upcoming-presentations-national 2026-06-03T08:00:41-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-upcoming-presentations-alzheimers 2026-07-01T08:00:32-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-18 2026-07-02T16:01:13-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-and-menarini-group-receive-positive-chmp 2026-07-24T08:00:32-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-host-investor-day-august-5-2026 2026-07-29T08:00:30-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-provides-corporate-update-and-reports-7 2026-08-05T07:00:55-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-19 2026-08-06T16:01:19-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-announces-upcoming-presentations-european 2026-08-26T08:01:06-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-participate-upcoming-investor-conferences-8 2026-09-02T08:00:35-04:00 0.5 https://ir.newamsterdampharma.com/news-releases/news-release-details/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-20 2026-09-03T16:01:31-04:00 0.5 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-1/0001104659-20-128041 2020-11-20T17:26:13-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/drs/0001104659-20-115324 2020-11-21T00:14:18-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-a12b/0001104659-20-132424 2020-12-04T16:15:11-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001104659-20-133271 2020-12-08T17:33:42-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001104659-20-133270 2020-12-08T17:33:46-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001104659-20-133273 2020-12-08T17:35:33-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001104659-20-133275 2020-12-08T17:36:07-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001104659-20-133276 2020-12-08T17:36:45-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001104659-20-133274 2020-12-08T17:36:46-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001104659-20-133279 2020-12-08T17:38:24-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001104659-20-133277 2020-12-08T17:38:25-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-20-003445 2020-12-09T06:04:12-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-1mef/0001104659-20-133354 2020-12-09T06:06:54-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b4/0001104659-20-134286 2020-12-10T17:23:42-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001104659-20-134761 2020-12-11T16:08:52-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001104659-20-135253 2020-12-14T16:09:10-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001104659-20-136830 2020-12-17T16:05:55-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3a/0001104659-20-136843 2020-12-17T16:08:58-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3a/0001104659-20-136842 2020-12-17T16:08:58-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3a/0001104659-20-136837 2020-12-17T16:09:09-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3a/0001104659-20-136840 2020-12-17T16:09:12-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3a/0001104659-20-136838 2020-12-17T16:09:17-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3a/0001104659-20-136844 2020-12-17T16:10:03-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13d/0001193125-21-019263 2021-01-27T16:50:22-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-21-022609 2021-01-29T16:09:02-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13g/0001104659-21-024219 2021-02-16T17:05:25-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-k/0001193125-21-096599 2021-03-26T16:29:48-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/nt-10-q/0001193125-21-163622 2021-05-18T00:18:15-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-21-170817 2021-05-24T16:04:03-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-ka/0001193125-21-170830 2021-05-24T16:04:53-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-21-171117 2021-05-24T17:29:46-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13g/0001104659-21-076356 2021-06-03T16:07:47-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-21-240492 2021-08-09T16:46:00-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001104659-20-128043 2021-08-15T22:36:32-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001104659-20-132420 2021-08-15T22:36:32-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001104659-20-132422 2021-08-15T22:37:03-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-21-324421 2021-11-09T16:09:04-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-22-018368 2022-01-26T16:54:48-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-ka/0001193125-22-023432 2022-01-31T16:43:20-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-qa/0001193125-22-023438 2022-01-31T16:45:47-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001104659-22-021224 2022-02-14T06:25:56-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001104659-22-022782 2022-02-14T16:24:29-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13g/0001172661-22-000701 2022-02-14T17:09:23-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-k/0001193125-22-085304 2022-03-25T17:20:01-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-22-147717 2022-05-12T06:09:52-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-22-200486 2022-07-25T08:24:25-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-ka/0001193125-22-200973 2022-07-25T17:16:46-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-200984 2022-07-25T17:21:58-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-203670 2022-07-27T17:32:44-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-203674 2022-07-28T06:09:02-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-204810 2022-07-28T16:10:52-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-208626 2022-08-01T16:04:24-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-212606 2022-08-04T16:49:28-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-214858 2022-08-08T16:08:27-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-216141 2022-08-09T16:24:55-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-218593 2022-08-11T16:32:54-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-218600 2022-08-11T16:35:45-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-22-218740 2022-08-11T17:29:53-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-218744 2022-08-11T17:30:29-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-222408 2022-08-16T17:08:34-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-223293 2022-08-17T16:33:05-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-225423 2022-08-19T17:03:01-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-227542 2022-08-23T16:38:08-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-228627 2022-08-24T17:05:46-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-228635 2022-08-24T17:08:16-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-232769 2022-08-29T16:16:35-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-22-008154 2022-09-20T00:08:35-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-22-008902 2022-09-20T00:08:38-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001193125-22-224145 2022-09-20T00:09:25-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-22-247366 2022-09-20T06:10:08-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-247715 2022-09-20T16:33:49-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-248086 2022-09-21T08:39:39-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-249188 2022-09-22T16:18:28-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-250161 2022-09-23T16:17:30-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-253405 2022-09-28T17:35:32-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-254392 2022-09-29T17:03:19-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-257602 2022-10-04T16:18:09-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-258204 2022-10-05T16:18:01-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-258209 2022-10-05T16:19:50-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-260107 2022-10-11T06:13:34-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-262239 2022-10-13T17:09:34-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-263757 2022-10-17T16:45:49-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/defm14a/0001193125-22-264485 2022-10-18T16:46:42-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13g/0001140361-22-039468 2022-11-02T08:26:25-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13d/0001140361-22-039877 2022-11-03T17:15:24-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001140361-22-040054 2022-11-04T18:01:07-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001140361-22-040057 2022-11-04T18:22:14-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-22-281196 2022-11-09T16:16:04-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13g/0001193805-22-001532 2022-11-14T16:46:17-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001193805-22-001540 2022-11-14T18:16:15-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-22-285506 2022-11-15T12:59:58-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/425/0001193125-22-286672 2022-11-16T15:05:57-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/25-nse/0001354457-22-000660 2022-11-22T16:18:13-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/25-nse/0001354457-22-000661 2022-11-22T16:18:54-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/25-nse/0001354457-22-000662 2022-11-22T16:19:42-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-22-292025 2022-11-23T16:12:55-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000899243-22-036923 2022-11-23T16:25:56-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000899243-22-036925 2022-11-23T16:28:26-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000899243-22-036924 2022-11-23T16:28:28-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000899243-22-036927 2022-11-23T16:31:05-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000899243-22-036936 2022-11-23T16:33:46-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-22-292061 2022-11-23T16:38:51-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001140361-22-043107 2022-11-25T13:40:39-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001140361-22-043112 2022-11-25T13:45:23-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001193805-22-001629 2022-12-01T16:53:49-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/15-12g/0001193125-22-297570 2022-12-02T16:33:36-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-22-308349 2022-12-19T16:25:17-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/f-1/0001193125-22-308510 2022-12-20T06:10:38-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-004215 2023-01-09T08:33:55-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-006539 2023-01-11T17:02:40-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/f-1a/0001193125-23-008945 2023-01-17T08:10:34-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-008951 2023-01-17T08:14:39-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-23-000220 2023-01-31T06:14:22-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-020321 2023-01-31T16:05:57-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-024918 2023-02-06T08:12:45-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-037365 2023-02-14T08:20:41-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001172661-23-001218 2023-02-15T10:16:13-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-23-000172 2023-03-01T00:12:40-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001193125-23-008949 2023-03-01T00:27:07-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001193125-23-016222 2023-03-01T00:27:47-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-060135 2023-03-03T16:52:49-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-062164 2023-03-07T08:26:10-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-8/0001193125-23-086736 2023-03-31T07:38:16-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-086865 2023-03-31T08:38:50-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/20-f/0000950170-23-011412 2023-03-31T16:38:40-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-088965 2023-04-03T08:24:48-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/pos-am/0001193125-23-102996 2023-04-17T09:15:17-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-111816 2023-04-24T08:11:38-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-23-001026 2023-04-25T06:11:12-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-114229 2023-04-25T08:16:38-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-137718 2023-05-08T08:31:50-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-137723 2023-05-08T08:35:41-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-151160 2023-05-23T08:17:27-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-151162 2023-05-23T08:17:28-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-157287 2023-05-31T08:02:39-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-160369 2023-06-05T08:52:14-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-161639 2023-06-06T16:22:08-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-163591 2023-06-08T17:05:43-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-23-164408 2023-06-09T15:50:42-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-164675 2023-06-12T06:48:45-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-164677 2023-06-12T06:49:11-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-23-166095 2023-06-13T17:05:47-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13g/0001140361-23-030497 2023-06-20T16:33:14-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-171138 2023-06-21T16:03:15-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-171141 2023-06-21T16:05:52-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13d/0001193125-23-183868 2023-07-07T17:03:20-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-23-183874 2023-07-07T17:07:44-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-194094 2023-07-26T08:04:32-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001104659-23-086394 2023-08-01T16:31:24-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0000950170-23-038741 2023-08-07T07:29:03-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-204473 2023-08-07T07:42:39-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/pos-am/0001193125-23-204488 2023-08-07T08:04:10-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-23-002352 2023-08-14T06:13:01-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-212443 2023-08-14T16:54:37-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-23-213432 2023-08-15T16:05:41-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-213502 2023-08-15T16:53:44-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-222609 2023-08-28T16:17:28-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001193125-23-237890 2023-09-20T06:08:58-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-239082 2023-09-21T07:17:49-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-239086 2023-09-21T07:25:04-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-240939 2023-09-25T08:12:27-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-260375 2023-10-23T08:19:17-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/6-k/0001193125-23-275412 2023-11-13T09:22:17-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-275415 2023-11-13T09:23:02-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/f-3/0001193125-23-290704 2023-12-07T16:17:49-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-23-298655 2023-12-19T16:37:54-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-23-003688 2023-12-20T06:07:03-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073855 2023-12-29T16:33:37-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073867 2023-12-29T16:34:14-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073856 2023-12-29T16:34:17-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073862 2023-12-29T16:34:21-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073858 2023-12-29T16:34:24-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073864 2023-12-29T16:34:27-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073859 2023-12-29T16:34:38-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073861 2023-12-29T16:35:16-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073860 2023-12-29T16:35:53-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073866 2023-12-29T16:36:35-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073863 2023-12-29T16:37:12-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-23-073906 2023-12-29T17:06:14-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000899243-23-020705 2023-12-29T17:13:05-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-24-000235 2024-01-02T16:04:04-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-001104 2024-01-03T17:16:27-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-001112 2024-01-03T17:16:41-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-001116 2024-01-03T17:17:58-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-001128 2024-01-03T17:20:13-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-001125 2024-01-03T17:20:13-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-001133 2024-01-03T17:23:05-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-001141 2024-01-03T17:25:57-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-001166 2024-01-03T17:33:02-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-001933 2024-01-04T08:10:03-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-003956 2024-01-08T08:25:00-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-24-003151 2024-01-08T19:49:39-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-003155 2024-01-08T19:50:17-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-23-013686 2024-01-22T01:14:52-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001193125-23-296402 2024-01-22T01:15:45-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-011701 2024-01-22T08:04:18-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3a/0000950170-24-007483 2024-01-25T17:04:43-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3a/0000950170-24-007482 2024-01-25T17:05:03-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b5/0001193125-24-033967 2024-02-13T17:34:32-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0000905148-24-000615 2024-02-14T10:14:05-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001104659-24-024010 2024-02-14T17:02:44-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b5/0001193125-24-037547 2024-02-15T16:16:21-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-037559 2024-02-15T16:20:01-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-24-040964 2024-02-21T11:14:24-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-018045 2024-02-21T17:06:07-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-k/0000950170-24-021668 2024-02-28T08:04:38-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-049263 2024-02-28T08:13:32-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/pos-am/0001193125-24-050794 2024-02-28T17:19:18-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-24-056055 2024-03-01T16:31:57-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-056922 2024-03-04T08:09:06-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-24-000622 2024-03-11T06:05:52-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-24-065893 2024-03-12T16:19:48-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001974158-24-000017 2024-03-26T17:41:18-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-037241 2024-03-27T16:35:31-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001415889-24-009330 2024-03-28T16:39:03-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-082723 2024-04-01T08:19:23-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-040235 2024-04-02T16:33:47-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/pos-am/0001193125-24-094677 2024-04-12T16:17:15-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-24-001001 2024-04-18T06:10:12-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-24-102926 2024-04-19T16:23:25-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/pre-14a/0001193125-24-122691 2024-04-29T17:02:32-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-24-052925 2024-05-03T16:19:04-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0000950170-24-055767 2024-05-08T16:33:43-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-24-056292 2024-05-09T08:03:58-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/def-14a/0001193125-24-135282 2024-05-09T16:17:03-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/ars/0001193125-24-135293 2024-05-09T16:20:47-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-157374 2024-06-07T16:17:28-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-158751 2024-06-11T08:14:58-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-076468 2024-06-24T08:32:16-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-3/0001193125-24-175069 2024-07-03T16:33:29-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-8/0001193125-24-175076 2024-07-03T16:35:57-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-24-002157 2024-07-15T06:24:51-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-180754 2024-07-18T08:13:37-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-24-084940 2024-07-19T16:33:07-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-24-084941 2024-07-19T16:33:07-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-084945 2024-07-19T16:33:19-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-186747 2024-07-29T08:32:36-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-24-092279 2024-08-07T08:02:37-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0000950170-24-092281 2024-08-07T08:04:15-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b5/0001193125-24-197964 2024-08-09T17:22:49-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-197971 2024-08-09T17:24:37-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/pos-am/0001193125-24-197977 2024-08-09T17:26:15-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001193125-24-176818 2024-08-10T00:07:42-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-24-007705 2024-08-10T00:08:20-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-24-002491 2024-08-13T06:08:25-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-099871 2024-08-22T16:32:53-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001193125-24-206196 2024-08-23T16:21:52-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-110440 2024-09-30T17:26:23-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0002004379-24-000001 2024-10-01T17:12:48-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-110955 2024-10-01T17:27:27-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-114388 2024-10-11T17:04:08-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-239687 2024-10-18T16:53:35-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/20-fa/0000950170-24-117574 2024-10-28T08:06:42-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-24-121827 2024-11-06T08:02:49-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0000950170-24-121828 2024-11-06T08:05:43-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001973141-24-000554 2024-11-13T16:29:45-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13ga/0001104659-24-119286 2024-11-14T17:50:08-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-24-259852 2024-11-15T16:33:01-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-127643 2024-11-15T16:41:01-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-260923 2024-11-18T16:13:40-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-128607 2024-11-19T16:18:07-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-262125 2024-11-20T07:15:41-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001193125-24-239684 2024-12-04T00:09:08-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-24-012197 2024-12-04T00:09:16-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001193125-24-196905 2024-12-04T00:09:28-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-24-011067 2024-12-04T00:09:35-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-24-008468 2024-12-04T00:09:35-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-273959 2024-12-10T07:28:53-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-274327 2024-12-10T16:04:02-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b5/0001193125-24-274386 2024-12-10T16:49:43-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-3mef/0001193125-24-276065 2024-12-11T20:04:55-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-135796 2024-12-12T16:18:55-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b5/0001193125-24-277565 2024-12-13T06:35:56-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-24-277937 2024-12-13T08:31:12-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-136642 2024-12-16T16:17:45-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-24-280208 2024-12-17T10:33:21-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-24-280472 2024-12-17T16:03:21-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-137335 2024-12-17T17:07:52-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/sc-13da/0001193125-24-280575 2024-12-17T17:36:33-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-137893 2024-12-18T16:17:02-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-139069 2024-12-20T16:27:51-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-140408 2024-12-26T16:22:28-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-24-141146 2024-12-30T16:19:37-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-000445 2025-01-02T16:17:25-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002356 2025-01-06T17:49:36-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002363 2025-01-06T17:54:48-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002370 2025-01-06T17:57:35-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002369 2025-01-06T17:57:46-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002372 2025-01-06T17:58:07-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002374 2025-01-06T18:00:49-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-8/0001193125-25-002861 2025-01-07T16:37:10-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002973 2025-01-07T17:10:16-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002988 2025-01-07T17:15:57-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002979 2025-01-07T17:15:58-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-002996 2025-01-07T17:19:19-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-003024 2025-01-07T17:26:52-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-003022 2025-01-07T17:26:53-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-003018 2025-01-07T17:26:59-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-003556 2025-01-08T18:00:04-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-003552 2025-01-08T18:00:04-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-003561 2025-01-08T18:07:43-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-003566 2025-01-08T18:10:46-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-003570 2025-01-08T18:13:21-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-25-004142 2025-01-10T08:29:36-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001973141-25-000014 2025-01-10T16:30:28-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-25-000052 2025-01-27T16:55:39-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-25-000053 2025-01-27T17:13:18-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-010575 2025-01-29T17:17:41-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-010594 2025-01-29T17:28:50-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-011854 2025-01-31T17:04:26-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/0000905148-25-000679 2025-02-14T16:51:21-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/0001415889-25-004299 2025-02-14T18:44:28-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-024322 2025-02-20T17:27:10-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-25-027336 2025-02-26T08:10:38-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-k/0000950170-25-027339 2025-02-26T08:13:02-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-3/0001193125-25-042775 2025-02-28T17:07:40-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0002004379-25-000001 2025-03-04T18:55:35-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-033927 2025-03-05T18:14:20-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001415889-25-007263 2025-03-06T17:34:33-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/424b3/0001193125-25-051062 2025-03-10T16:53:54-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/effect/9999999995-25-000628 2025-03-11T06:09:50-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-042176 2025-03-19T17:32:00-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-045283 2025-03-26T16:29:45-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-25-000242 2025-03-26T18:07:24-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-25-000244 2025-03-26T18:23:07-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-046934 2025-03-28T17:18:25-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-046943 2025-03-28T17:20:54-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-046947 2025-03-28T17:23:08-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-046958 2025-03-28T17:27:43-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-046962 2025-03-28T17:32:30-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001415889-25-009198 2025-03-28T17:39:24-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/upload/0000000000-25-002386 2025-04-08T00:09:15-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/corresp/0001193125-25-048333 2025-04-08T00:09:23-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001973141-25-000177 2025-04-11T20:04:21-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-25-084428 2025-04-17T17:07:50-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-25-055601 2025-04-17T17:40:43-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-055603 2025-04-17T17:40:43-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-055612 2025-04-17T17:44:21-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-056395 2025-04-21T17:43:20-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/pre-14a/0001193125-25-100723 2025-04-28T16:48:59-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-062894 2025-05-02T16:57:00-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-062897 2025-05-02T16:58:18-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-25-114456 2025-05-07T07:38:24-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-25-066410 2025-05-08T08:05:04-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0000950170-25-066413 2025-05-08T08:06:20-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/def-14a/0001193125-25-115995 2025-05-08T16:28:13-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/ars/0001193125-25-116006 2025-05-08T16:30:53-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13g/0001422848-25-000095 2025-05-13T11:46:05-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-25-000363 2025-05-15T16:41:49-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13ga/0001415889-25-013208 2025-05-15T16:59:46-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-074463 2025-05-19T16:46:57-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-081072 2025-06-03T17:08:57-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0000950170-25-081069 2025-06-03T17:08:57-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-081087 2025-06-03T17:09:06-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-25-137119 2025-06-06T16:36:39-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-25-137432 2025-06-09T07:35:26-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-25-084663 2025-06-11T09:08:53-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001470831-25-000050 2025-06-18T12:33:03-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001415889-25-017693 2025-06-18T16:45:57-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-087937 2025-06-18T16:52:34-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001415889-25-018316 2025-06-26T19:44:48-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-25-158211 2025-07-11T16:30:14-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001969223-25-000508 2025-07-14T16:13:58-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-096665 2025-07-17T17:21:41-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-25-099891 2025-07-30T08:28:00-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-25-103520 2025-08-06T07:02:46-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0000950170-25-103521 2025-08-06T07:04:59-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13da/0000950170-25-107390 2025-08-12T16:31:27-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13ga/0001422849-25-000040 2025-08-13T12:58:38-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001415889-25-021660 2025-08-13T16:52:37-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-25-109387 2025-08-15T16:07:23-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-25-109567 2025-08-18T08:03:12-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13da/0001415889-25-022506 2025-08-20T17:29:15-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0002056296-25-000009 2025-08-25T17:04:38-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-111241 2025-08-25T17:06:40-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0002004379-25-000002 2025-08-27T16:58:14-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-111738 2025-08-27T17:13:26-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0000950170-25-112345 2025-09-02T08:34:08-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0002004379-25-000005 2025-09-03T08:22:17-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-113088 2025-09-04T17:47:46-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-113276 2025-09-05T17:09:04-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001974494-25-000102 2025-09-09T12:01:37-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001415889-25-024111 2025-09-10T17:24:04-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0000950170-25-114033 2025-09-10T17:44:24-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001341382-25-000007 2025-09-17T17:24:38-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13da/0001193125-25-225170 2025-09-30T16:49:09-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13da/0001231919-25-000416 2025-11-04T17:24:49-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-25-265796 2025-11-05T08:07:46-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-25-265800 2025-11-05T08:10:59-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13da/0001193125-25-272748 2025-11-07T19:26:41-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13ga/0001422849-25-000077 2025-11-13T19:15:10-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0000950130-25-000295 2025-12-02T21:23:26-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001193125-25-305717 2025-12-02T21:24:53-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001193125-25-305720 2025-12-02T21:27:36-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13da/0001193125-25-308141 2025-12-04T16:31:40-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-25-001282 2025-12-23T17:32:08-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-25-335513 2025-12-29T17:17:58-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001974494-26-000013 2026-01-05T15:04:25-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001974494-26-000015 2026-01-05T15:06:09-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001974494-26-000017 2026-01-05T15:20:54-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000015 2026-01-06T16:30:59-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001974494-26-000023 2026-01-07T13:26:06-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-006658 2026-01-07T18:28:55-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-006659 2026-01-07T18:34:18-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-006662 2026-01-07T18:34:30-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-008300 2026-01-09T08:04:29-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-009270 2026-01-09T19:38:10-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-009273 2026-01-09T19:38:10-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-009271 2026-01-09T19:38:22-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-009272 2026-01-09T19:38:22-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-009274 2026-01-09T19:38:23-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-009268 2026-01-09T19:38:33-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-009269 2026-01-09T19:39:18-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000040 2026-01-20T16:18:19-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-019686 2026-01-22T17:28:51-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-025012 2026-01-27T17:42:07-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-029526 2026-01-29T16:46:32-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13g/0000315066-26-000486 2026-02-05T13:33:18-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13ga/0000905148-26-000880 2026-02-17T16:28:25-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-056020 2026-02-18T07:03:52-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-k/0001193125-26-056029 2026-02-18T07:06:18-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-8/0001193125-26-056037 2026-02-18T07:09:04-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0002085929-26-000002 2026-02-20T07:54:35-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000152 2026-02-24T16:23:50-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-067260 2026-02-24T16:42:05-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-078718 2026-02-26T21:45:13-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-084266 2026-03-02T08:04:19-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000187 2026-03-02T16:13:39-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-085947 2026-03-02T18:10:20-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000230 2026-03-05T16:15:01-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000241 2026-03-06T17:53:34-05:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-099073 2026-03-09T20:20:46-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-100798 2026-03-10T21:02:35-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000272 2026-03-11T16:14:04-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-104239 2026-03-12T16:29:51-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/pre-14a/0001193125-26-162757 2026-04-20T08:03:14-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-177406 2026-04-24T16:33:37-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/def-14a/0001193125-26-207562 2026-05-06T07:22:20-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/ars/0001193125-26-207564 2026-05-06T07:24:17-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13ga/0000315066-26-001273 2026-05-06T11:31:29-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-26-210272 2026-05-07T07:04:27-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-210283 2026-05-07T07:05:24-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13da/0001193125-26-224656 2026-05-14T19:53:59-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000491 2026-05-26T17:05:30-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-241983 2026-05-27T16:32:58-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-254615 2026-06-03T08:00:20-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13ga/0001422849-26-000108 2026-06-04T18:33:00-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/s-8/0001193125-26-259794 2026-06-05T16:42:27-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-281062 2026-06-24T16:12:23-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-312390 2026-07-22T16:07:02-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-312387 2026-07-22T16:08:21-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-315163 2026-07-24T08:05:14-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/10-q/0001193125-26-333824 2026-08-05T07:10:17-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-333827 2026-08-05T07:10:17-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/schedule-13ga/0000315066-26-002082 2026-08-06T10:35:31-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-k/0001193125-26-352186 2026-08-14T16:11:04-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/3/0001193125-26-352209 2026-08-14T16:15:17-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/8-ka/0001193125-26-352233 2026-08-14T16:18:51-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144/0001968582-26-000868 2026-08-24T16:57:49-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-365202 2026-08-25T16:33:42-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/144a/0001968582-26-000878 2026-08-25T16:48:13-04:00 0.4 https://ir.newamsterdampharma.com/sec-filings/sec-filing/4/0001193125-26-381953 2026-09-03T16:33:40-04:00 0.4 https://ir.newamsterdampharma.com/board-member/louis-lange 2022-10-21T16:16:32-04:00 0.5 https://ir.newamsterdampharma.com/board-member/juliette-audet 2022-10-21T16:17:15-04:00 0.5 https://ir.newamsterdampharma.com/board-member/john-w-smither 2023-05-12T18:12:27-04:00 0.5 https://ir.newamsterdampharma.com/board-member/janneke-van-der-kamp 2023-10-16T15:57:26-04:00 0.5 https://ir.newamsterdampharma.com/analyst/dennis-ding 2023-10-30T15:36:12-04:00 0.5 https://ir.newamsterdampharma.com/analyst/roanna-ruiz-phd 2023-10-30T15:34:05-04:00 0.5 https://ir.newamsterdampharma.com/analyst/leonid-timashev-phd 2023-10-30T15:34:49-04:00 0.5 https://ir.newamsterdampharma.com/analyst/matthew-phipps-phd 2023-10-30T15:35:34-04:00 0.5 https://ir.newamsterdampharma.com/analyst/sebastiaan-van-der-schoot 2024-02-28T12:02:38-05:00 0.5 https://ir.newamsterdampharma.com/board-member/william-lewis 2024-01-08T17:48:41-05:00 0.5 https://ir.newamsterdampharma.com/analyst/yasmeen-rahimi-phd 2024-01-16T11:22:21-05:00 0.5 https://ir.newamsterdampharma.com/analyst/debjit-chattopadhyay-phd 2024-01-18T18:13:42-05:00 0.5 https://ir.newamsterdampharma.com/analyst/tyler-van-buren 2024-05-15T11:47:05-04:00 0.5 https://ir.newamsterdampharma.com/board-member/mark-mckenna 2024-07-19T16:32:16-04:00 0.5 https://ir.newamsterdampharma.com/analyst/serge-belanger 2024-09-04T16:02:02-04:00 0.5 https://ir.newamsterdampharma.com/analyst/steve-seedhouse 2025-06-05T13:08:48-04:00 0.5 https://ir.newamsterdampharma.com/analyst/james-condulis 2025-06-09T18:19:29-04:00 0.5 https://ir.newamsterdampharma.com/analyst/geoff-meacham 2025-06-17T09:53:40-04:00 0.5 https://ir.newamsterdampharma.com/analyst/asad-haider 2025-07-23T15:59:17-04:00 0.5 https://ir.newamsterdampharma.com/analyst/yanan-zhu 2025-08-25T08:34:55-04:00 0.5 https://ir.newamsterdampharma.com/analyst/joseph-pantginis 2026-09-03T10:52:36-04:00 0.5 https://ir.newamsterdampharma.com/analyst/srikripa-devarakonda-phd 2026-03-27T12:45:13-04:00 0.5 https://ir.newamsterdampharma.com/board-member/adele-gulfo 2026-04-22T09:41:52-04:00 0.5 https://ir.newamsterdampharma.com/analyst/conor-mackay 2026-07-20T17:46:06-04:00 0.5